Long-Circulating Immunoliposomal Amphotericin B against Invasive Pulmonary Aspergillosis in Mice
Long-Circulating Immunoliposomal Amphotericin B against Invasive Pulmonary Aspergillosis in Mice
复制标题
长循环免疫脂质体两性霉素 B 对抗小鼠侵袭性肺曲霉病
DOI:
--
复制
发表时间:
1998
影响因子:
4.9
通讯作者:
S. Kohno
中科院分区:
文献类型:
--
作者:
T. Otsubo;K. Maruyama;S. Maesaki;Y. Miyazaki;Eitaro Tanaka;T. Takizawa;K. Moribe;K. Tomono;T. Tashiro;S. Kohno
ABSTRACT We investigated the efficacy of long-circulating immunoliposomal amphotericin B (AmB) against invasive pulmonary aspergillosis in mice using three types of liposomal AmB: conventional liposomal AmB (AmBisome), a long-circulating liposomal AmB and prepared by coating the liposome surface with polyethylene glycol (PEG; PEG-L-AmB), long-circulating immunoliposomal AmB (34A-PEG-L-AmB). The survival rates for mice with invasive pulmonary aspergillosis treated with an intravenous dose of 2 mg of AmBisome, PEG-L-AmB, or 34A-PEG-L-AmB per kg of body weight were 16.7, 83.3, and 100%, respectively. Treatment with 34A-PEG-L-AmB produced a marked reduction in the number ofAspergillus fumigatus organisms in the lungs. Pharmacokinetic studies showed the presence of high AmB concentrations in the plasma of mice treated with PEG-L-AmB (40.8 μg/ml) and in the lungs of mice treated with 34A-PEG-L-AmB (42.3 μg/g). We conclude that 34A-PEG-L-AmB, a long-circulating immunoliposomal AmB, is a promising form of AmB against invasive pulmonary aspergillosis.
登录
查看更多内容
影响因子:
3.8
作者:
Maruyama,K;Holmberg,E;Kennel,SJ;Klibanov,A;Torchilin,VP;Huang,L
通讯作者:
Huang,L
DOI:
10.1016/0005-2736(90)90381-w
发表时间:
1990
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
Jullien,S;Brajtburg,J;Bolard,J
通讯作者:
Bolard,J
影响因子:
11.2
作者:
Hughes,BJ;Kennel,S;Lee,R;Huang,L
通讯作者:
Huang,L
DOI:
10.1016/0005-2736(91)90385-l
发表时间:
1991-02-25
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
KLIBANOV, AL;MARUYAMA, K;HUANG, L
通讯作者:
HUANG, L
影响因子:
3.6
作者:
Krause,HJ;Juliano,RL
通讯作者:
Juliano,RL